Global Cancer CDK Inhibitor Market 2019-2029 - Pipeline Analysis is estimated to be US$ 16.1 billion by 2030 with a CAGR of 10.4% during the forecast period - by PMI Covina CA, March 17, 2021 (GLOBE NEWSWIRE) -- The Global Cancer CDK Inhibitor Market accounted for US$ 6.0 billion in 2019 and is estimated to be US$ 16.1 billion by 2029 and is anticipated to...

Adhera Therapeutics Provides Third Quarter 2018 Financial Results and Business Update Research Triangle Park, NC, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), an emerging specialty pharmaceutical company commercializing therapies that leverage its...